4//SEC Filing
Celldex Therapeutics, Inc. 4
Accession 0001179110-13-011400
$CLDXCIK 0000744218operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 8:51 AM ET
Size
5.4 KB
Accession
0001179110-13-011400
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option
2013-07-01+115,000→ 115,000 totalExercise: $16.36From: 2014-07-01Exp: 2023-07-01→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]25% vest on July 1, 2014 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000744218
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 8:51 AM ET
- Size
- 5.4 KB